HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.

Abstract
Histiocytic sarcoma (HS) is a rare neoplasm of uncertain etiology. Most recently, the diagnostic criteria for this entity have been revised with inclusion of diagnostic modalities such as immunohistochemical and cytogentic techniques. HS tends to have an aggressive clinical course and presents with systemic symptoms of fever, weight loss, adenopathy, hepatosplenomegly, rash, and pancytopenia. Thalidomide is a promising agent that may exert a therapeutic benefit in HS. We report a case of a 48-year-old female with HS who presented with fever, weight loss, fatigue, generalized anasarca, and pancytopenia. She underwent multi-agent chemotherapy followed by matched unrelated hematopoietic stem cell transplant. Her disease recurred and thalidomide therapy was started, with her overall disease burden significantly reduced as measured radiographically.
AuthorsMuneer H Abidi, Isaacson Tove, Rami B Ibrahim, Dan Maria, Edward Peres
JournalAmerican journal of hematology (Am J Hematol) Vol. 82 Issue 10 Pg. 932-3 (Oct 2007) ISSN: 0361-8609 [Print] United States
PMID17617785 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Angiogenesis Inhibitors
  • Cytarabine
  • Thalidomide
  • Vincristine
  • Etoposide
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
  • Prednisone
Topics
  • Angiogenesis Inhibitors (therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Cisplatin (administration & dosage)
  • Combined Modality Therapy
  • Cyclophosphamide (administration & dosage)
  • Cytarabine (administration & dosage)
  • Dexamethasone (administration & dosage)
  • Disease Progression
  • Doxorubicin (administration & dosage)
  • Etoposide (administration & dosage)
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Histiocytes (pathology)
  • Humans
  • Middle Aged
  • Prednisone (administration & dosage)
  • Retroperitoneal Neoplasms (drug therapy, pathology, surgery)
  • Sarcoma (drug therapy, pathology, surgery)
  • Thalidomide (therapeutic use)
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: